Search

everythinglearnresearchcommunity

for

Search:↓

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib may help treat severe hair loss, but more research is needed.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib is effective and safe for treating alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

An arthritis drug helped a person with severe hair loss regrow their hair.

ITK inhibitors may effectively treat alopecia areata.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.